explore -WSS

explore

author：knowledge 2025-08-12 06:37:59 - browse：84225

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Be careful with at

entertainment

WSS

Biden administration begins canceling student loan debt for 804,000 borrowers

Surge in Apellis stock fueled by confidence in safety of its eye drug

What to know about the judge who will handle the Trump case

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Aspartame and sugar

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

focus

explore

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

Dewpoint Therapeutics lays off staff after losing partnerships

Virginia high school admissions case could be legal follow

After Optum profits sink, UnitedHealth makes changes

Trump demands the U.S. pay no more for drugs than other countries … again

eGenesis tests gene

At least 13 dead in Texas as scorching temps continue

Why doctors need education on FDA device approval process

Alkermes shareholders re

Megan Rapinoe shares emotional post following US Women's World Cup exit

hotspot

Test for long Covid? Researchers find new clue in blood samples

Francis Collins on trust in science and how Covid communications failed

Aspartame and sugar

After Optum profits sink, UnitedHealth makes changes

Novo Nordisk touts Wegovy study, but still struggling with supply

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

focus

hotspot

entertainment

focus